General Information of the Compound
| Compound ID |
CP0917315
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-{[3-(4-{[6-({(2R)-2-Hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)phenyl]methyl}-2,4,5-imidazolidinetrione formate salt
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H41N3O9
|
||||||||||||||||||
| Molecular Weight |
587.67
|
||||||||||||||||||
| Canonical SMILES |
O=C1NC(=O)N(Cc2cccc(CCCCOCCCCCCNC[C@H](O)c3ccc(O)c(CO)c3)c2)C1=O.O=CO
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H39N3O7.CH2O2/c33-20-24-17-23(11-12-25(24)34)26(35)18-30-13-4-1-2-5-14-39-15-6-3-8-21-9-7-10-22(16-21)19-32-28(37)27(36)31-29(32)38;2-1-3/h7,9-12,16-17,26,30,33-35H,1-6,8,13-15,18-20H2,(H,31,36,38);1H,(H,2,3)/t26-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UNYLFZSGSBJEFG-SNYZSRNZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor